Stocktoria
Black Hawk Acquisition Corp BKHA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-03-21
Chart by TradingView
2/9
Piotroski F — financial health
-2.21
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 |
|---|---|---|
| Financials | ||
| Operating income | -$915,510 | -$576,076 |
| Net income | $1.3M | $1.9M |
| Operating cash flow | -$650,321 | -$553,665 |
| Total assets | $23.9M | $72.1M |
| Total liabilities | $3.9M | $2.5M |
| Shareholders' equity | -$3.8M | -$2.2M |
| Ratios | ||
| Return on assets | 5.6% | 2.7% |
| Return on equity | -34.6% | -88.2% |
| Current ratio | 0.03 | 4.42 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -2.21 (distress)
- Working capital / assets -0.06
- Retained earnings / assets -0.161
- EBIT / assets -0.038
- Equity / liabilities -0.987
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0002000775 · as of 2025-11-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.